EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
Barbara Kiesewetter,
Nathan I Cherny,
Nicolas Boissel,
Francesco Cerisoli,
Urania Dafni,
Elisabeth G E de Vries,
Paolo Ghia,
Nicola Gökbuget,
Verónica González-Calle,
Brian Huntly,
Ulrich Jäger,
Nicola Jane Latino,
Jean-Yves Douillard,
Luca Malcovati,
María-Victoria Mateos,
Gert J Ossenkoppele,
Kimmo Porkka,
Markus Raderer,
Josep-Maria Ribera,
Lydia Scarfò,
Ruth Wester,
Panagiota Zygoura,
Pieter Sonneveld
Feb 10, 2020
Objective: Value frameworks in oncology have not been validated for the assessment of treatments in haematological malignancies, but to avoid overlaps and duplications it appears reasonable to build up experience on existing...